Avertim in Life Sciences & Chemicals

Recent price pressures have been challenging Life Science & Chemicals companies due to various factors, including health authorities focusing intensively on value of innovation for patients, increased (European) regulation for Medical Devices or in-vitro-diagnostics or inflation and price increases on raw materials.

Companies in this sector must walk a fine line between – seemingly conflicting – priorities. They must embrace digitalization, striving towards data-driven innovations and informed decisions-making, leading to a more efficient, controlled and ever-evolving organisation. On the other hand, emerging technologies and delivering strong results from product development pipelines to keep providing value for customers is key. At the same time, a pressure on operational costs due to rising interest rates and supply chain imbalances, as a result of global instability, leads to a focus on operational excellence and cost efficiency.

Finally, regulatory pressures with new regulation on all aspects of the Life sciences & chemicals sector are being implemented, such as CSDR, leading to novel ways of thinking about operating a company in a sustainable way, and require implementation of new solutions. It is essential that companies in this sector connect strategy and operations management to steer towards success. The pressures above lead to companies needing to rethink how they manage risk, control operating costs, and define new roadmaps and ambitions.

HOW AVERTIM CAN HELP:

We have been working with the leading companies that have defined the course of the industry for more than 15 years. Avertim’s mission is to translate client’s strategy into actionable projects and enable business, technology and management alignment. We have developed a unique industry expertise and are able to guide you through the challenges the industry is facing today.

We offer consulting advice and services through our methodologies within the life sciences industry following our seven service lines:

Strategy & Corporate Finance

Business development strategy and corporate finance have never been more under more pressure. With constantly changing uncertainties (geopolitics, inflation, climate transformation) and options (cheap capital, liquidity, risks, technology and data), life science & chemicals companies are forced to identify what matters most and ensure strategic decisions can be made. Avertim provides advice and services in defining, addressing, and activating companies' strategies and finance activities.

Avertim can offer support in business strategy, adaptation and assessment. Other than that, strategic sourcing and developing your non-organic strategy lies within our capabilities. Furthermore, we can help with improving Finance function excellence and post-merger integration.

Sales & Marketing

Companies are facing challenges to grow in a competitive market. Growth is the reflection of strong values of the company that meet the needs of customers. Making an impact on costumers can be achieved by understanding the customer, design strong company values and deliver the relevant solutions.

Avertim focuses on the omnichannel experience, launch excellence and patient experience. Furthermore we can help in the patient & customer journey mapping and value-based healthcare implementation.

Digital & Analytics

S&C industry needs to embrace digital and emerging technologies to stay relevant. The digital transformation within the industry is in full force. Avertim provides a full range of digital solutions from assessment to implementation, leveraging our strengths to translate strategy towards implementation in collaboration with our clients.

Avertim can support you in developing a rationale for digitalization (including maturity assessment, business case, transformation plan and global to local strategy translation. Furthermore, we are able implement digital solutions such as a digital roadmap, digital twins, control towers, QMS/LIMS/MES implementation, advanced analytics, machine learning technologies and forecasting models. Another important value Avertim will bring is ensuring successful implementation of digital solutions across the value chain (KPI tracking, digital project & portfolio management and digital collaboration).

Operations

Companies are facing an increased pressure on successful development, acquisition and launch of new therapies, leading to an increasing pressure on their research and development process and development pipeline in a highly competitive environment.

We are experienced following services in Operations: change- project- and business management. Within R&D we offer alliance management support and Avertim can also handle CDMO management. Our capabilities also include early & late stage project and portfolio management and life cycle management.

Quality, Risk and Compliance

The Life Sciences & Chemicals industry operates under strict oversight to ensure the development, production and distribution of pharmaceutical and chemical products meet strict standards, making compliance a crucial aspect along the entire value chain.

Important offerings that we are able to offer are Audit & inspection readiness, incoming materials management, quality event management, quality risk assessment, qualification and validation activities, data integrity & CSV. We also offer support in moving towards a green Industry, tech transfers and regulatory & compliance support.

Business Transformation

Business transformation is essential within Life Sciences & Chemicals companies to survive today’s challenges companies are facing. From disruption and lack of resources to changes in people management and the socio-economic environment, the current challenges require resilience. Companies benefit from Business Transformation by increased efficiency, profitability, employee wellbeing, service and outcome improvements.

Avertim is experienced in the following areas: facilitating vision definition, setting-up and executing transformation office, managing portfolio, customizing a change management journey and coaching of middle management.

Evolution Towards Sustainability

The Life Science & Chemicals industry is making significant progress in the journey towards becoming a sustainable and green industry. Companies are integrating sustainability into their operations and are addressing health issues such as patient safety, access to healthcare.

Avertim can help you In your journey towards sustainability with life cycle management, sustainable operational excellence, CSRD reporting and patient value & centricity support.

Want to know about our CSR initiatives? Check out our sustainability page

Future challenges

Regulatory and quality compliance

Set up proper risk-monitoring, quality systems and culture to leverage on compliance for better products and services

Research & Development profitability

Control spending and ensure sufficient results and payoffs to preserve revenue base in a context of increased competition and government subsidies reduction

Emerging markets and outsourcing

Increasing emerging markets demand, low-value activities outsourcing and R&D relocation to attractive countries force companies to look after flexibility and efficiency in third parties management (eg: CDMO, CRO...)